2016 Pipeline Café Participants
The Pipeline Café features academic innovators who are hand selected to present their discoveries, which are available for partnering, in two poster sessions. The academic innovators will be available for discussions at their posters as well as one-on-one partnering meetings.
Targeting Next-Generation Local Anesthetics for the Treatment of Ocular Pain
Jeffrey Petruska, PhD, Chief Scientific Officer and Co-Founder, Anesigen, Inc.
Imaging and Targeting VEGF Receptors in Cancer and Cardiovascular Diseases
Joseph M. Backer, PhD, Chief Executive Officer, SibTech, Inc.
First-in-class TREM-1 targeted magic bullet therapy for cancer, autoimmune diseases, atherosclerosis, and retinopathy
Alexander B. Sigalov, PhD, President, Founder & Principal Investigator, SignaBlok, Inc.
Novel Mechanisms for Enhancement of Cellular DNA Repair After UV Exposure
Pengbo Zhou, PhD; Frank Borchetta, JD, CEO and President, Repairogen
Steroid Analogs for Combination Anti-TB Therapy
Nicole S. Sampson, PhD, Professor and Chair, Xinxin Yang, PhD, Senior Postdoctoral Fellow, Tianao Yuan, Graduate Student, Department of Chemistry, Stony Brook University
Calreticulin: a novel biotherapeutic for tissue repair and regeneration for multiple applications
Leslie I. Gold, PhD, Chief Scientific Officer, CalRegen, Inc
Aptamer-linked Nanoparticles for Targeted Therapy, Radiosensitization, and Imaging of Diverse Cancer Types
Paula Bates, PhD, ExCITE Program Director and Associate Professor of Medicine, University of Louisville
Translating Ribosomal Control into Novel Cancer Therapeutics
Judith Hemberger, PhD, MBA, Chief Executive Officer, SuviCa
Quantitative, Point-of-Care Immunoassay Platform to Guide and Monitor Sickle Cell Disease Therapy
Frank Wang, PhD, Chief Executive Officer, BioMedomics
IC-100: A Novel Therapeutic to Treat Central Nervous System Injury and Disease
Robert W. Keane, PhD, Founder, InflamaCORE
Autologous Brown Adipose Tissue Therapy for the Treatment of Obesity and Type II Diabetes
Brian Gillette, PhD, Founder, Ardent Cell Technologies
A Nanotherapeutic Strategy to Target Disseminated Tumors
Daniel A. Heller, PhD, Assistant Member, Memorial Sloan Kettering Cancer Center
Injectable Cellulosic Hydrogels for Soft Tissue Replacement
Steven B. Nicoll, PhD, Chief Scientific Officer and Co-Founder, Cellulomedix, LLC
Novel microRNA Mimics for Colon Cancer Therapeutic Development
Jingfang Ju, PhD, Associate Professor, Co-Director of Translational Research Laboratory, Department of Pathology, Stony Brook University
Delivering Antibodies to the Neuronal Cytoplasm via Recombinant Botulinum Neurotoxin
Philip Band, PhD, Co-Founder and Chief Executive Officer, CytoDel, LLC
Fesarius Therapeutics: Maker of Innovative Engineered Tissue Products that Help People Heal
Jason A. Spector, MD, FACS, Professor of Plastic Surgery and Otolaryngology, Director, Laboratory of Bioregenerative Medicine and Surgery, Weill Cornell Medicine
Bret Spector, Chief Executive Officer, Fesarius Therapeutics
TissueB2B: Connecting Bedside to Bench: Building a Centralized Tissue Information Platform
Kunal R. Chaudhary, PhD, Department of Radiation Oncology, Columbia University Medical Center
View our 2015 Pipeline Café participants here.